Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1990 1
1992 1
1994 1
1995 3
1996 1
1997 2
1998 2
1999 5
2000 1
2001 2
2002 5
2003 4
2004 9
2005 4
2006 6
2007 4
2008 9
2009 8
2010 14
2011 22
2012 15
2013 14
2014 39
2015 60
2016 57
2017 60
2018 73
2019 74
2020 120
2021 112
2022 152
2023 140
2024 47

Text availability

Article attribute

Article type

Publication date

Search Results

955 results

Results by year

Filters applied: . Clear all
Page 1
Algorithm for optimized mRNA design improves stability and immunogenicity.
Zhang H, Zhang L, Lin A, Xu C, Li Z, Liu K, Liu B, Ma X, Zhao F, Jiang H, Chen C, Shen H, Li H, Mathews DH, Zhang Y, Huang L. Zhang H, et al. Nature. 2023 Sep;621(7978):396-403. doi: 10.1038/s41586-023-06127-z. Epub 2023 May 2. Nature. 2023. PMID: 37130545 Free PMC article.
Retraction.
[No authors listed] [No authors listed] J Biochem Mol Toxicol. 2022 Jun;36(6):e23033. doi: 10.1002/jbt.23033. Epub 2022 Mar 23. J Biochem Mol Toxicol. 2022. PMID: 35318771
Yu, M, Yu, H-L, Li, Q-H, Zhang, L, Chen, Y-X. miR-4709 overexpression facilitates cancer proliferation and invasion via downregulating NR3C2 and is an unfavorable prognosis factor in colon adenocarcinoma. ...
Yu, M, Yu, H-L, Li, Q-H, Zhang, L, Chen, Y-X. miR-4709 overexpression facilitates cancer proliferation and invasion via …
Retraction Note.
Listed NA. Listed NA. Eur Rev Med Pharmacol Sci. 2024 Feb;28(3):861. doi: 10.26355/eurrev_202402_35364. Eur Rev Med Pharmacol Sci. 2024. PMID: 38375730 Free article.
The following articles: - "Long non-coding RNA MNX1-AS1 promoted osteosarcoma proliferation and invasion via inhibiting KISS1" by Y.-X. Zhang, H.-X. Cui, L. Liu, G.-K. Yi, published in Eur Rev Med Pharmacol Sci 2019; 23 (14): 6045-6052-DOI: 10.26355/eurrev_201907_18417-PMI …
The following articles: - "Long non-coding RNA MNX1-AS1 promoted osteosarcoma proliferation and invasion via inhibiting KISS1" by Y.-X. Z …
Antimicrobial d-Peptide Hydrogels.
Guo Z, Wang Y, Tan T, Ji Y, Hu J, Zhang Y. Guo Z, et al. ACS Biomater Sci Eng. 2021 Apr 12;7(4):1703-1712. doi: 10.1021/acsbiomaterials.1c00187. Epub 2021 Mar 5. ACS Biomater Sci Eng. 2021. PMID: 33667076
KKd-11 was found to self-assemble into a hydrogel with an improved long-term antimicrobial ability and a better antiprotease activity as compared to the hydrogel formed by Ac-(L)K(L)H(L)H(L)Q(L)K(L)L(L)V(L)F(L)F(L)A(L)K-NH(2) (KK-11). Our results indic …
KKd-11 was found to self-assemble into a hydrogel with an improved long-term antimicrobial ability and a better antiprotease activity as com …
M2 Macrophage Hybrid Membrane-Camouflaged Targeted Biomimetic Nanosomes to Reprogram Inflammatory Microenvironment for Enhanced Enzyme-Thermo-Immunotherapy.
Chen R, Yang J, Wu M, Zhao D, Yuan Z, Zeng L, Hu J, Zhang X, Wang T, Xu J, Zhang J. Chen R, et al. Adv Mater. 2023 Sep;35(39):e2304123. doi: 10.1002/adma.202304123. Epub 2023 Jul 28. Adv Mater. 2023. PMID: 37339776
An M2 macrophage-erythrocyte hybrid membrane-camouflaged biomimetic nanosized liposome (USM[H]L) is engineered to deliver targeted self-cascading bienzymes and immunomodulators to reprogram the inflammatory microenvironment in gouty rats. ...Proinflammatory M1 macro …
An M2 macrophage-erythrocyte hybrid membrane-camouflaged biomimetic nanosized liposome (USM[H]L) is engineered to deliver targ …
A safe and potent anti-CD19 CAR T cell therapy.
Ying Z, Huang XF, Xiang X, Liu Y, Kang X, Song Y, Guo X, Liu H, Ding N, Zhang T, Duan P, Lin Y, Zheng W, Wang X, Lin N, Tu M, Xie Y, Zhang C, Liu W, Deng L, Gao S, Ping L, Wang X, Zhou N, Zhang J, Wang Y, Lin S, Mamuti M, Yu X, Fang L, Wang S, Song H, Wang G, Jones L, Zhu J, Chen SY. Ying Z, et al. Nat Med. 2019 Jun;25(6):947-953. doi: 10.1038/s41591-019-0421-7. Epub 2019 Apr 22. Nat Med. 2019. PMID: 31011207 Free PMC article. Clinical Trial.
955 results